Abstract
Methods for modeling a human illness must have relevance to the clinical description of the abnormal condition, and they should be capable of generating an experimental condition that responds to the treatments commonly used with that disorder. In the case of mania, there are some immediate problems with definition of the syndrome. The following discussion is based on the American Psychiatric Association’s DSM-III (1980) classifications of mania and depression. However, it is suggested that this classification may be deficient in some important respects (Lyon, 1990), and any critique of neuromethods for inducing an animal state resembling mania must take these shortcomings into account.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association (1980) DSM-III: Diagnostic and Statistical Manual of Mental Disorchs, 3rd Ed. American Psychiatric Association, Washington, DC.
Andreasen N. C. and Powers P. S. (1975) Creativity and psychosis. An examination of conceptual style. Arch. Gen. Psychiat 32, 70–73.
Antelman S. M. and Chiodo L. A. (1981) Dopamine autoreceptor subsensitivity: A mechanism common to the treatment of depression and the induction of amphetamine psychosis? Biol. Psychiat. 16, 717–727.
Arnt J. and Scheel-Kruger J. (1979) GABA in the ventral tegmental area: Differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists. Life Sci. 25, 1351–1360.
Ayhan I. and Randrup A. (1973) Behavioural and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines. Psychopharmacol. (Berl.) 29, 317–328.
Balsara J. J., Jadhav J. K, Muley M. P., and Chandorkar A. G. (1979) Effect of drugs influencing central serotonergic mechanisms on methamphet-amine-induced stereotyped behavior in the rat. Psychopharmcol. 64, 303–307.
Barchas J. D., Evans C., Elliott G. R., and Berger P. A. (1985) Peptide neuroregulators: The opioid system as a model. Yale J. Biol. Med. 58, 579–596.
Beckmann H. and Heinemann H. (1976) d-Amphetamin beim manischen Syndrom. Arzneim-Forschungen (Drug Res.) 26(6), 1185,1186.
Berger P. A. and Barchas J. D. (1982) Studies of beta-endorphin in psychiatric patients, in Opioids in Mental Illness: Theories, Clinical Observations, and Treatment Possbilities, Vol. 398 (Verebey K, ed.) Ann. NY Acad. Sci., NY, pp. 448–459.
Bleuler E. (1950) Dementia Praeccx. International University Press, NY.
Bogerts B., Meertz E., and Schonfeldt-Bausch R. (1985) Basal ganglia and limbic system pathology in schizophrenia. Arch. Gen. Psychiat. 42, 784–791.
Boissier J.-R. (1975) L’utilisation des sels de lithium en therapeutique. Annales pharmaceutiques francaises 33(8-9), 447–458.
Brodie H. K. H., Murphy D. L, Goodwin P. K., and Bunney W. E., Jr. (1971) Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism. Clin. Pharmacol. Theraphy l2, 218.
Brown T. H., Chapman P. P, Kairiss E. W, and Keenan C. L. (1988) Long-term synaptic potentiation. Science 242, 724–728.
Brown W. A. and Mueller B. (1979) Alleviation of manic symptoms with catecholamine agonists. Am. J Psychiat 136(2), 230,231.
Carlsson A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuroysychopharmacol. 1(3), 179–186.
Chiodo L. A. and Antelman S. M. (1980) Electroconvulsive shock: Progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 210, 799–801.
Cooper J. R., Bloom P. E., and Roth R. H. (1986) The Biochemical Basis of Neurophamacology, 5th Ed., Oxford University Press, NY, p. 400.
Coscina D. V., Seggie J., Godse D. D., and Stancer H. C. (1973) Induction of rage in rats by central injection of 6-hydroxydopamine, Pharmacol. Biochem. Behav. 1, 1–6.
Coscina D. V, Goodman J., Godse D. D., and Stancer H. C. (1975) Taming effects of handling on 6-hydroxydopamine induced rage. Pharmacol, Biochem. Behav. 3, 525–528.
Costall B., Domeney A. M, and Naylor R. J. (1984a) Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action. Psychoyharmacol. 82, 174–180.
Costall B., Domeney A. M, and Naylor R. J. (1984b) Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion. Neuropharmacol, 23, 287–294.
Davies C., Sanger D. J., Steinberg H., Tomkiewicz M., and U’Prichard D. C. (1974) Lithium and alpha-methyl-y-tyrosine prevent ′manic′ activity in rodents. Psychopharmacol. (Berl.) 36, 263–274.
Davis J. M., Janowsky D., Tamminga C., and Smith R. C. (1978) Cholinergic mechanisms in schizophrenia, mania and depression, in ChoZinergic Mechanisms and Psychophurmacology (Jenden D. J., ed.), Plenum, NY, pp. 805–815.
Davis K. L., Berger P. A., Hollister L. E., Domaral J. R., and Barchas J. D. (1978) Cholinergic dysfunction in mania and movement disorders, in Cholinergic Mechanisms and Psychopharmacology (Jenden D. J., ed.) Plenum, NY, pp. 755–779.
DeVietti T. L., Pellis S. M., Pellis V. C., and Teitelbaum P. (1985) Previous experience disrupts atropine-induced stereotyped “trapping” in rats. Behav. Neurosci. 99, 1128–1141.
de Wied D. (1979) Schizophrenia as an inborn error in the degradation of beta-endorphin—a hypothesis. Trends in Neurosci. 2, 79–82.
Diaz J., Ellison G., and Matsuoka D. (1974) Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5, 6dihydroxytryptamine. Psychopharmacol, (Berl.) 37, 67–79.
Dilsaver S. C. and Greden J. F. (1984) Antidepressant withdrawal-induced activation (hypomania and mania): Mechanism and theoretical significance. Brain Res. Rev. 7, 29–48.
Eison M. S., Eison A. S., and Iversen S. D. (1983) Two routes of continuous amphetamine administration induce different behavioral and neurochemical effects in the rat. Neurosci. Lett., 39, 313–319.
Ellinwood E. H, Jr. and Kilbey M. M. (1977) Chronic stimulant intoxication models of psychosis, in Animal Models in Psychiatry and Neurology, (Hanin I., and Usdin E, eds.) Pergamon, Oxford, UK, pp. 61–74.
Ellison G. and Bresler O. (1974) Tests of emotional behavior in rats following depletion of norepinephrine, of serotonin, or both. Psychopharmacol. (Berl.) 34, 275–288.
Evenden J. L. and Robbins T. W. (1983) Increased response switching perseveration and perseveration switching following d-amphetamine in the rat. Psychopharmacol. 80, 67–73.
Evetts K. D., Uretsky N. J., Iversen L. L, and Iversen S. D. (1970) Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity and amphetamine-induced hyperactivity in rats. Nature 225, 961,962.
Fessler R. G., Sturgeon R. D, London S. F., and Meltzer H. Y. (1982) Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Psychopharmacol. 78, 373–376.
Fibiger H. C. and Campbell B. A. (1971) The effect of parachlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacol. 10, 25–32.
Fischman M. W. and Schuster C, R. (1974) Tolerance development to chronic methamphetamine intoxication in the rhesus monkey. Pharmacol. Biochem. Behav. 2, 503–508.
Fonnum F. (1984) Glutamate: A neurotransmitter in mammalian brain. J. Neurochem. 42, 1–11.
Gallistel C. R. (1986) The role of the dopaminergic projections in MPB self-stimulation. Behav. Brain Res. 20, 313–321.
Gerner R. H., Post R. M., and Bunney W. E., Jr. (1976) A dopaminergic mechanism of mania. Am.J. Psychiat. 133, 1177–1179.
Gerson SC, and Baldessarini R. J. (1980) Minireview: Motor effects of serotonin in the central nervous system. Life Sci. 27, 1435–1451.
Gilies P. H, Leviton A, and Dooling E. C. (1983) The Developing Human Brain, Growth and Eyidkmiological Neuropathology, Wright PSG, Boston, MA.
Goddard G. V., McIntyre D. C., and Leech C. K (1969) A permanent change in brain function resulting from daily electrical stimulation. Exptl. Neural. 25, 295–301.
Grahame-Smith D. G. (1971) Studies in vivo on the relationships between brain tryptophan, brain 5-HT synthesis, and hyperactivity in rats treated with a MAO inhibitor and 2-tryptophan. J. Neurochem. l8, 1053–1066.
Green A. R. and Grahame-Smith D. G. (1974) The role of brain dopamine in the hyperactivity syndrome produced by increased Li-hydroxy-tryptamine synthesis in rats. Neuropharmacol, 13, 949–959.
Harrison J. M. and Lyon M, (1957) The role of the septal nuclei and the components of the fornix in the behavior of the rat. J. Corny. Neural. 108, 121–137.
Heikkila R. E., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of l-methyl4phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224, 1451–1453.
Herberg L. J. and Franklin K. B. J. (1976) The ′stimulant′ action of tryptophan-monoamine oxidase inhibitor combinations: Suppression of self-stimulation. Neuropharmacol. 15, 349–351.
Hill R. T. (1970) Facilitation of conditioned reinforcement as a mechanism for psychomotor stimulation, in Amphetamines and Related Compounds, (Costa E. and Garattini S, eds.) Raven, NY, pp. 791–795.
Hiramatsu K., Kameyama T, Saitoh O, Niwa S., Rymar K., and Itoh K. (1984) Correlations of event-related potentials with schizophrenic deficits in information processing and hemispheric dysfunction. Biol. Psychol. 19, 281–294.
Huberman H. S., Eison M. S., Bryan K., and Eilison G. (1977) A slow-release pellet for chronic amphetamine administration. Eur. J. Pharmacol. 45, 237–240.
Iversen S. D. (1977) Striatal function and stereotyped behaviour, in The Psychobiology of the Striatum (Cools A. R., Lohman A. H. M., and van der Bercken J. H. L., eds.), North-Holland, Amsterdam, pp. 99–118.
Iversen S. D. (1986) Animal models of schizophrenia, in The Psychopharmacolony and Treatment of Schizophrenia (Bradley P. B. and Hirsch S. R., eds.), Oxford University Press, Oxford, UK.
Jackson D. M., Bailey R. C., Christie M. J., Crisp E. A., and Skerrit J. H. (1981) Long-term d-amphetamine in rats: Lack of change in postsynaptic dopamine receptor sensitivity. Psychopharmacol. 73, 276–280.
Jacobs B. L. (1976) An animal behaviour model for studying central serotonergic synapses. Life Sci. 19, 777–786.
Jacobs B. L., Trulson M. E, and Stem W. C. (1976) An animal behavior model for studying the action of LSD and related hallucinogens. Science 194, 741–743.
Jakob H. and Beckmann H. (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenia. J. Neurotrans. 65, 303–326.
Janowsky D. S., El-Yousef M. K, Davis J. M, Hubbard B., and Sekerke H. J. (1972a) A cholinergic adrenergic hypothesis of mania and depression. Lancet 2, 632–635.
Janowsky D. S., El-Yousef M. K., Davis J. M, and Sekerke H. J. (1972) Cholinergic antagonism of methylphenidate-induced stereotyped behavior. Psychopharmacologia (Berl.) 27, 295–303.
Janowsky D. S., El-Yousef M. K., Davis J. M., and Sekerke H. J. (1973) Para-sympathetic suppression of manic symptoms by physostigmine. Arch. Gen. Psychiat. 28, 542–547.
Jones G. H., Hemandez T. D., and Robbins T. W. (1987) Isolation-rearing impairs the acquisition of schedule-induced polydipsia. Abst. Soc. Neurosci. 13, 405.
Jones G. H., Marsden C. A., and Robbins T. W. (1989) Hypersensitivity to reward-related stimuli and to intra-accumbens d-amphetamine following social deprivation in rats. Soc. Neurosci. Abst. Vol. 15(1), p. 412.
Joyce E. M. and Iversen S. D. (1979) The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14, 207–212.
Kantak K. M. (1988) Magnesium deficiency alters aggressive behavior and catecholamine function. Behav. Neurosci. 102, 303–331.
Karson C. N, Dykman R. A., and Paige S. R. (1990) Blink rates in schizophrenia. Schiz. Bull. 16(2), 345–354.
Katz R. J. (1982) Morphine-and endorphin-induced behavioral activation in the mouse: Implications for mania and some recent pharmacogenetic studies, in Opioids in Mental Illness, vol. 398 (Verebey K, ed.), Ann. NY Acad. Sci., NY, pp. 291–300.
Kelly P. H. and Iversen L. L. (1975) LSD as an agonist at mesolimbic dopamine receptors. Psychopharmacologia (Berl.) 45, 221–224.
Kelly P. H., Seviour P. W, and Iversen S. D. (1975) Amphetamine and apomorphine response in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94, 507–522.
Kovelman J. A. and Scheibel A. B. (1984) A neurohistological correlate of schizophrenia. Biol. Psychiat. 19, 1601–1621.
Kuczenski R. and Segal D. (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9(6), 2051–2065.
Leith N. J. and Barrett R. J. (1980) Effects of chronic amphetamine or reserpine on self-stimulation responding: Animal model of depression? Psychopharmacol. 72, 9–15.
Lorens S. A., Guldberg H. C., Hole K, Kohler C., and Srebro B. (1976) Activity, avoidance learning and regional 5hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res. 108, 97–113.
Lyon M. (1990) Animal models of mania and schizophrenia, in Behaviourul Models in Psychopharmacology (Willner P., ed.), Cambridge University Press, Cambridge, UK.
Lyon M. and Barr C. E. (in press) Possible interactions of obstetrical complications and abnormal fetal brain development in schizophrenia, in Fetal Neural Developnent and Adult Schizophrenia (Mednick S. A., Cannon T. D., Barr C. E., and Lyon M., eds.), Cambridge University Press, NY.
Lyon M. and Nielsen E. B. (1979) Psychosis and drug induced stereotypies, in Psychopathology in Animals: Research and Clinical implications (Keehn J. D., ed.), Academic, NY, pp. 103–142.
Lyon M. and Randrup A. (1972) The dose-response effect of amphetamine upon avoidance behavior in the rat seen as a function of increasing stereotypy. Psvchopharmacologia (Berl.) 23, 324–347.
Lyon M. and Robbins T. W. (1975) The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects, in Current Develoyments in Psychopharmacology, Vo1 2. (Essman W. and Valzelli L., eds.), Spectrum, NY, pp. 79–163.
Lyon N. and Gerlach J. (1988) Perseverative structuring of responses by schizophrenic and affective disorder patients. J. Psychiat. Res. 23, 261–277.
Lyon N., Mejsholm B., and Lyon M. (1986) Stereotyped responding in schizophrenic outpatients: Cross-cultural confirmation of perseverative switching on a two-choice task. J. Psychiat. Res. 20, 137–150.
Mailman R. B., Lewis M. H, and Kilts C. D. (1981) Animal models related to developmental disorders: Theoretical and pharmacological analyses. Appl. Res. Ment. Retard. 2, 1–12.
Marsden C. A. and Curzon G. (1976) Studies on the behavioural effects of tryptophan and p-chlorophenylalanine. Neuropharmacology 15, 165–171.
Martin-Iverson M. T., Stahl S. M., and Iversen S. D. (1988) Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization. Psychopharmacol. 95, 534–539.
McGinity J. W. and Mehta C. S. (1978) Preparation and evaluation of a sustained morphine delivery system in rats. Pharmacol, Biochem. Behav. 9, 705.
Mehrabian A. (1986) Arousal-reducing effects of chronic stimulant use. Motivation and Emotion 10(1), 1–10.
Meltzer H. L., Taylor R. M., Platman S. R., and Fieve R. R. (1969) Rubidium: A potential modifier of affect and behaviour. Nature 223, 321–322.
Miller F. P., Cox R. H., Snodgrass W. R., and Maikel R. P. (1970) Comparative effects of γ-chlorophenylalanine, γ-chloroamphetamine, and γ-chloro-N methylamphetamine on rat brain norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19, 435–442.
Murphy D. L. (1977) Animal models for mania, in Animal Models in Psychiatry and Neurology (Hanin I. and Usdin E, eds.), Pergamon, NY, pp. 211–222.
Nakamura K and Thoenen H. (1972) Increased iritability—A permanent behavior change induced in the rat by intraventricular administration of 6-hydroxydopamine. Psychopharmacologiu (Berl.) 24, 359–372.
Nielsen E. B. (1981) Rapid decline of stereotyped behavior in rats during constant one week administration of amphetamine via implanted ALZET® osmotic minipumps. Pharmacol. Biochem. Behav. 15, 161–165.
Nielsen E. B., Lyon M., and Ellison G. (1983) Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. J. Nerv. Ment. Dis. 171, 222–233.
Norton S., Mullenix P., and Culver B. (1976) Comparison of the structure of hyperactive behavior in rats after brain damage from X-irradiation, carbon monoxide and pallidal lesions. Brain Res. 116, 49–67.
Pavlinac D., Langer R., Lenhard L., and Deftos L. (1979) Magnesium in affective disorders. Biol. Psychiat. 14(4), 657–661.
Petty P. and Sherman A. D. (1981) A pharmacologically pertinent animal model of mania. J. Affect. Dis. 3, 381–387.
Phillips A. G., Carter D. A., and Fibiger H. C. (1976) Dopaminergic substrates of intracranial self-stimulation in the caudate-putamen. Brain Res. 104, 221–232.
Poitou P., Boulu R., and Bohuon C. (1975) Effect of lithium and other drugs on the amphetamine chlordiazepoxide hyperactivity in mice. Experientia 15(1), 99–101.
Post R. M. (1977) Approaches to rapidly cycling manic-depressive illness, in Animal Models in Psychiatry and Neurology (Hanin I. and Usdin E., eds.), Pergamon, NY, pp. 201–210.
Post R. M., Squillace K. M, Sass W., and Pert A. (1981) The effect of amygdaloid kindling on spontaneous and cocaine-induced motor activity and lidocaine seizures. Psychopharmacology 72, 189–196.
Post R. M., Rubinow D., and Ballenger J. (1984) Conditioning, sensitization, and kindling: Implications for the course of affective illness, in Neurobiology of Mood Disorders (Post R. M. and Ballenger J., eds.), Williams and Wilkins, Baltimore, pp. 432–466.
Post R. M., Weiss S. R. B., and Pert A. (1988) Cocaine-induced behavioral sensitization and kindling: Implications for the emergence of psychopathology and seizures, in The Mesocorticolimbic Doyamine System (Kalivas P. W. and Nemeroff C. B., eds.), Ann. NY Acad. Sci., NY, pp. 292–308.
Randrup A. and Munkvad I. (1968): Behavioural stereotypies induced by pharmacological agents. Pharmakopychiatri und Neuropsychopharmakologi 1, 18–26.
Randrup A., Munkvad I., and Fog R. (1981) Mental and behavioural stereotypies elicited by stimulant drugs. Relation to the dopamine hypothesis of schizophrenia, mania, and depression, in Recent Advances in Neuropsychopharmacology (Angrist B., Burrows G. D., Lader M., Lingjaerde O., Sedvall G., and Wheatley D, eds.), Pergamon, Oxford, UK, pp. 63–74.
Rastogi R. B., Merali Z., and Singhal R. L. (1977) Cadmium alters behaviour and biosynphetic capacity for catecholamine and serotonin in neonatal rat brain. J. Neurochem. 28, 789–794.
Robbins T. W. (1975) The potentiation of conditioned reinforcement by psychomotor stimulant drugs: A test of Hill’s hypothesis. Psychopharmacologia (Berl.) 45, 103–112.
Robbins T. W. (1976) Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs. Nature (Land.) 254, 57–59.
Robbins T. W. (1978) The acquisition of responding with conditioned reinforcement: Effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine. Psychopharmacol. 58, 79–87.
Robbins T. W. and Sahakian B. J. (1980) Animal models of mania, in Maniu: An Evolving Concept (Belmaker R. and van Praag H, eds.), Spectrum, NY, pp. 143–216.
Robbins T. W., Watson B. A., Gaskin M., and Ennis C. (1983) Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacol. 80, 113–119.
Rubin E. H. and Zorumski C. F. (1985) Limbic seizures, kindling and psychosis: A link between neurobiology and clinical psychiatry. Comp. Ther. 1, 54–58.
Scheel-Kruger J. (1986) Dopamine-GABA interactions: Evidence that GAB A transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol. Scand. (Suppl.) 107, 1–54.
Scheel-Kruger J., Arnt J., Magelund G., Olianas M., Przewlocka B., and Christensen A. V. (1980) Behavioural functions of GABA in basal ganglia and limbic system. Brain Res. Bull. 5(2), 261–267.
Scheel-Kruger J., Magelund G, and Olianas M. C. (1981) Role of GABA in the striatal output system: Globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus, in GABA and the Basal Ganglia, Advances in Biochemistry and Psychopharmacology, Vol. 30 (Di Chiara G. and Gessa G. L., eds.), pp. 165–186.
Schiørring E. (1971) Amphetamine induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats. Behaviour 39, 1–17.
Schwartz B. (1986) Allocation of complex sequential operants on multiple and concurrent schedules of reinforcement. J. Exp. Anal. Behav. 45, 283–295.
Schwartz J. M., Ksir C, Koob G. P., and Bloom F. E. (1982) Changes in locomotor response to beta-endorphin microinfusion during and after opiate abstinence syndrome—A proposal for a model of the onset of mania. Psychiat. Res. 7, 153–161.
Silbergeld E. K. and Goldberg A. M. (1974) Lead-induced behavioral dysfunction: An animal model of hyperactivity. Exptl. Neural. 42, 146–157.
Stevens J. R. (1975) GABA blockade, dopamine and schizophrenia: Experimental activation of the mesolimbic system. Int. J. Neural. 10, 115–127.
Stevens J. R. (1979) Schizophrenia and dopamine regulation in the mesolimbic system. Trends Neurosci. 2, 102–105.
Sudilovsky A. (1975) Effects of disulfiram on the amphetamine-induced behavioral syndrome in the cat as a model of psychosis. National Institute on Drug Abuse Research, Monograph Series 3, pp. 109–135.
Taylor J, R. and Robbins T. W. (1984) Enhanced behavioral control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology 84, 405–412.
Thompson D. M. (1973) Repeated acquisition of response sequences: Effects of d-amphetamine and chlorpromazine. Pharmacol. Biochem. Behav. 2, 741–746.
U’Prichard D. C. and Steinberg H. (1972) Selective effects of lithium on two forms of spontaneous activity. Br. J. Pharmacol. 44, 349,350.
Van de Kar L. D. and Lorens S. A. (1979) Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and medial midbrain raphe nuclei. Brain Res. 162, 45–54.
Van Ree J. M., Verhoeven W. M. A., de Wied D., and van Praag H. M. (1982) The use of synthetic peptides y-type endorphins in mentally ill patients, in Opioids in Mental Illness: Theories, Clinical Obsewations, and Treatment Possibilities, Vol. 398 (Verebey K., ed.), Ann. NY Acad. Sci., NY, pp. 487–495.
Villablanca J. R., Harris C. M, Burgess J. W, and de Andres I. (1984) Reassessing morphine effects in cats: I. Specific behavioral responses in intact and unilaterally brain-lesioned arimals. Pharmacol. Biochem, Behav. 21, 913–921.
Vogel R. and Annau Z. (1973) An operant discrimination task allowing variability of reinforced response patterning. J. Exp. Anal. Behav. 20, 1–6.
Wake A. and Wada J. (1975) Frontal cortical kindling in cats. Can. J. Neural. Sci. 2, 493–496.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 The Humana Press Inc.
About this protocol
Cite this protocol
Lyon, M. (1991). Animal Models for the Symptoms of Mania. In: Boulton, A.A., Baker, G.B., Martin-Iverson, M.T. (eds) Animal Models in Psychiatry, I. Neuromethods, vol 18. Humana Press. https://doi.org/10.1385/0-89603-198-5:197
Download citation
DOI: https://doi.org/10.1385/0-89603-198-5:197
Publisher Name: Humana Press
Print ISBN: 978-0-89603-198-2
Online ISBN: 978-1-59259-623-2
eBook Packages: Springer Protocols